| 000 | 01345 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517235617.0 | ||
| 264 | 0 | _c20191028 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a1873-4286 | ||
| 024 | 7 |
_a10.2174/1381612824666180911114210 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFatima, Kaneez | |
| 245 | 0 | 0 |
_aThe Dual Specificity Role of Transcription Factor FOXO in Type 2-diabetes and Cancer. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2018 |
||
| 300 |
_a2839-2848 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 |
_aForkhead Transcription Factors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 700 | 1 | _aMathew, Shilu | |
| 700 | 1 | _aFaheem, Muhammed | |
| 700 | 1 | _aMehmood, Tahir | |
| 700 | 1 | _aYassine, Hadi Mohamad | |
| 700 | 1 | _aAl Thani, Asmaa A | |
| 700 | 1 | _aAbdel-Hafiz, Hany | |
| 700 | 1 | _aAl Ghamdy, Khalid | |
| 700 | 1 | _aQadri, Ishtiaq | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 24 _gno. 24 _gp. 2839-2848 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1381612824666180911114210 _zAvailable from publisher's website |
| 999 |
_c28826265 _d28826265 |
||